The Sudbury-based company signs a California health care provider

Content of the article

Flosonics Medical, a leader in wearable medical ultrasound based in Sudbury, announced that Sutter Health of Northern California will implement the FloPatch, the world’s first wireless, Doppler ultrasound device.

Content of the article

“We are excited to partner with Sutter Health to make this pioneering ultrasound technology available to their healthcare providers,” Joe Eibl, CEO of Flosonics Medical, said in a release. “FloPatch is a new paradigm that connects physiology and regenerative medicine.

“We believe it could revolutionize treatment for critical care patients by bringing much-needed insight into complex and urgent clinical situations.”

The FDA-cleared device gives ICU nurses a quick, hands-free way to monitor blood flow at the bedside to help guide cardiac disease and fluid management in critically ill patients.

One recent study showed for every 10 FloPatch tests performed in the emergency department, about four patients will avoid a potentially dangerous fluid, resulting in results that improved patient outcomes and significant cost savings.

Content of the article

Content of the article

Determining how much or how little intravenous fluid (IV) to give a patient is one of the most urgent, complex and error-prone steps in critical care. The FloPatch provides a simple, fast and consistent way to measure changes in blood flow and heart function associated with IV fluid volume.

By making it easier to administer IV fluids, FloPatch improves the care of critically ill patients, including those with septic shock, the leading cause of death in US hospitals.

Placed around the patient’s neck, the hands-free FloPatch continuously monitors blood flow in the carotid arteries, which provide a window into the left ventricle. FloPatch then wirelessly transmits that data to a secure iOS mobile device, providing clinicians with actionable, real-time information at the bedside.

Content of the article

Sutter Health will deploy FloPatch this summer at two Bay Area medical centers (for a total of four ICUs): first at Sutter’s Eden Medical Center in Castro Valley, Calif., and then at Sutter’s California Pacific Medical Center in San Francisco at CPMC Van Ness. , Davies and Mission Bernal campuses.

“Sepsis, hypotension/shock and renal failure are common clinical problems in the emergency department and ICU,” said Dr. Kristina Kury, medical director of Critical Care at Sutter’s Eden Medical Center. “FloPatch can have a significant impact on patient care by allowing targeted care, will prevent potentially dangerous interventions and, in some cases, may avoid the need for emergency care.” ICU.

“I believe this technology will provide accurate, actionable data that will allow us to improve patient care, reduce complications and reduce length of stay for many of our patients.”

Content of the article

Dr. George S. Horng, medical director of Critical Care at California Pacific Medical Center in Sutter, agreed. “Based on our first experience using the FloPatch, we believe it will be effective in managing the care of ICU patients with cardiac arrest and other critical conditions such as sepsis.

“This is a non-invasive breakthrough that will lead to better quality of life outcomes for our patients.”

Flosonics Medical is a Canadian medical device company based in Sudbury that researches and develops new ultrasound technologies.

Founded in 2015, the company’s mission is to improve patient care and the practice of medicine through solutions enabled by technology and medical health research. For more information please visit www.flosonicsmedical.com.

Sutter Health is a not-for-profit health care system that provides comprehensive care throughout California. It serves approximately 3.5 million patients and has a staff of more than 57,000 physicians, and 12,000 associate physicians, focused on expanding care to serve more patients.

sud.editorial@sunmedia.ca

X: @SudburyStar

Content of the article